Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$109.52 - $120.96 $5.43 Million - $6 Million
49,565 New
49,565 $5.63 Million
Q3 2023

Nov 02, 2023

BUY
$95.53 - $114.62 $4.99 Million - $5.99 Million
52,242 New
52,242 $5.06 Million
Q1 2023

Jun 27, 2023

BUY
$96.86 - $114.01 $5.09 Million - $5.99 Million
52,503 New
52,503 $5.32 Million
Q3 2022

Nov 03, 2022

BUY
$96.76 - $112.03 $99,372 - $115,054
1,027 Added 1.85%
56,580 $5.48 Million
Q2 2022

Aug 08, 2022

BUY
$102.07 - $123.37 $728,983 - $881,108
7,142 Added 14.75%
55,553 $6.04 Million
Q1 2022

May 09, 2022

BUY
$114.02 - $139.04 $5.52 Million - $6.73 Million
48,411 New
48,411 $5.73 Million
Q4 2021

Feb 02, 2022

SELL
$115.53 - $141.46 $7.47 Million - $9.15 Million
-64,692 Closed
0 $0
Q3 2021

Nov 08, 2021

BUY
$116.66 - $129.06 $7.55 Million - $8.35 Million
64,692 New
64,692 $7.64 Million
Q1 2021

May 13, 2021

SELL
$108.84 - $128.23 $5.45 Million - $6.42 Million
-50,042 Closed
0 $0
Q4 2020

Feb 09, 2021

BUY
$105.0 - $114.42 $5.25 Million - $5.73 Million
50,042 New
50,042 $5.48 Million
Q4 2019

Feb 10, 2020

SELL
$78.51 - $87.4 $2.73 Million - $3.04 Million
-34,810 Closed
0 $0
Q3 2019

Nov 08, 2019

BUY
$81.84 - $88.74 $2.85 Million - $3.09 Million
34,810 New
34,810 $2.91 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Duality Advisers, LP Portfolio

Follow Duality Advisers, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Duality Advisers, LP with notifications on news.